The Lottery Corporation Limited (ASX: TLC) has announced that Managing Director and CEO, Sue van der Merwe, will retire by the end of calendar year 2025, bringing to a close…
Telix Wins FDA Approval for Next-Generation Prostate Cancer Imaging Agent, Gozellix®
Melbourne & Indianapolis, March 21, 2025 – Telix Pharmaceuticals (ASX: TLX, Nasdaq: TLX) has secured FDA approval for Gozellix®, its next-generation PSMA-PET imaging agent for prostate cancer. This milestone expands…
Sigma Delivers Strong FY25 Performance Ahead of Chemist Warehouse Merger
Sigma Healthcare Limited (ASX: SIG) has reported a strong financial performance for the full year ended 31 January 2025, marking its final standalone results before merging with Chemist Warehouse Group…
Clover Delivers a Strong Turnaround Performance in 1H FY25
Clover Corporation Limited (ASX: CLV) has bounced back in a big way, delivering a 38% increase in revenue to $37.6 million for the first half of FY25. With net profit…
New Hope Delivers Strong Half-Year Results & Announces $100M Share Buyback
New Hope Corporation (ASX: NHC) has reported a 35% surge in net profit after tax (NPAT) to $340.3 million for the first half of FY25, driven by higher coal production…
Gold Road Updates on March 2025 Quarter Production at Gruyere
Gold Road Resources (ASX: GOR) has provided an update on expected production figures for the March 2025 quarter at the Gruyere Gold Mine, a 50:50 joint venture with Gold Fields…
NAB Announces Executive Leadership Team Changes
NAB Group CEO Andrew Irvine has announced several key changes to the bank’s Executive Leadership Team, including a new leader for Business & Private Banking (B&PB) and an upcoming transition…
Boss Energy Increases Stake in Queensland Uranium Developer Laramide Resources
Boss Energy Limited (ASX: BOE; OTCQX: BQSSF) is expanding its footprint in the uranium sector, announcing it has acquired an additional 23.5 million shares in Laramide Resources (TSX & ASX:…
Telix Expands Theranostic Pipeline with Completion of FAP-Targeting Acquisition
Telix Pharmaceuticals (ASX: TLX, Nasdaq: TLX) has officially completed its acquisition of Fibroblast Activation Protein (FAP)-targeting radiopharmaceutical candidates, further strengthening its theranostic pipeline in oncology. This deal, first announced in…
PolyNovo Announces CEO Change and Leadership Transition
Melbourne, March 2025 – PolyNovo Limited (ASX: PNV) has announced that Chief Executive Officer, Mr. Swami Raote, will step down from his role effective immediately, with non-executive director Dr. Robyn…